Cardiac effort is less variable than six-minute walk distance, correlates with hemodynamics and is consistent with REVEAL 2.0 risk score in a sub-study of the TORREY phase 2 PAH trial
Cardiac effort is less variable than six-minute walk distance, correlates with hemodynamics and is consistent with REVEAL 2.0 risk score in a sub-study of the TORREY phase 2 PAH trial
ATS – May 2024c
Now Enrolling: The PROSERA Phase 3 study of seralutinib in adults with Pulmonary Arterial Hypertension (PAH).
